
Sign up to save your podcasts
Or


In this episode, David interviews Dr. Hans Eriksson: clinical psychiatrist and Chief Medical Officer at HMNC Brain Health, which is currently in Phase 2 trials for Ketabon, a non-dissociative, prolonged-release oral capsule.
www.psychedelicstoday.com
By Psychedelics Today4.6
553553 ratings
In this episode, David interviews Dr. Hans Eriksson: clinical psychiatrist and Chief Medical Officer at HMNC Brain Health, which is currently in Phase 2 trials for Ketabon, a non-dissociative, prolonged-release oral capsule.
www.psychedelicstoday.com

817 Listeners

1,847 Listeners

2,624 Listeners

1,494 Listeners

631 Listeners

1,288 Listeners

1,018 Listeners

309 Listeners

1,046 Listeners

471 Listeners

185 Listeners

283 Listeners

114 Listeners

114 Listeners

148 Listeners